Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Crimson Wine (CWGL) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Crimson Wine (CWGL) over the last 12 years, with Q3 2025 value amounting to $700000.0.

  • Crimson Wine's Asset Writedowns and Impairment rose 7500.0% to $700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 19080.19%. This contributed to the annual value of $942000.0 for FY2024, which is 239.13% up from last year.
  • Per Crimson Wine's latest filing, its Asset Writedowns and Impairment stood at $700000.0 for Q3 2025, which was up 7500.0% from $500000.0 recorded in Q2 2025.
  • Over the past 5 years, Crimson Wine's Asset Writedowns and Impairment peaked at $899000.0 during Q4 2021, and registered a low of $100000.0 during Q2 2021.
  • For the 5-year period, Crimson Wine's Asset Writedowns and Impairment averaged around $407611.1, with its median value being $300000.0 (2022).
  • Per our database at Business Quant, Crimson Wine's Asset Writedowns and Impairment plummeted by 7964.4% in 2022 and then skyrocketed by 26140.35% in 2025.
  • Quarter analysis of 5 years shows Crimson Wine's Asset Writedowns and Impairment stood at $899000.0 in 2021, then crashed by 79.64% to $183000.0 in 2022, then increased by 20.22% to $220000.0 in 2023, then skyrocketed by 100.91% to $442000.0 in 2024, then surged by 58.37% to $700000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $700000.0 for Q3 2025, versus $500000.0 for Q2 2025 and $824000.0 for Q1 2025.